RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies.

RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies.

Item
http://www.wikidata.org/entity/Q35159896
Association Between RFC1 G80A Polymorphism and Acute Lymphoblastic Leukemia: a Review and Meta-Analysis of 10 StudiesOutcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature reviewThe association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies.Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis.Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.No Association Between Single-Nucleotide Polymorphism 56 (SNP56) in Phosphodiesterase 4D (PDE4D) Gene and Susceptibility to Ischemic Stroke: A Meta-Analysis of 15 Studies.Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies--a systematic review.The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers.Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis.Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models.Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis.Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.
P2860

RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies.

Item
http://www.wikidata.org/entity/Q35159896
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
RFC1 80G>A is a genetic determ ...... ysis of observational studies.
@ast
RFC1 80G>A is a genetic determ ...... ysis of observational studies.
@en
type
label
RFC1 80G>A is a genetic determ ...... ysis of observational studies.
@ast
RFC1 80G>A is a genetic determ ...... ysis of observational studies.
@en
prefLabel
RFC1 80G>A is a genetic determ ...... ysis of observational studies.
@ast
RFC1 80G>A is a genetic determ ...... ysis of observational studies.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
RFC1 80G>A is a genetic determ ...... ysis of observational studies.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698